Topics
Glioblastoma | Etiopathogenesis | Overview
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Overview
Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina
NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y,
Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon
DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H,
Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello
JF.
Glioblastoma evolution and
heterogeneity from a 3D whole-tumor perspective.
Cell.
2024 Jan 18;187(2):446-463.e16. doi:
10.1016/j.cell.2023.12.013. PMID:
38242087. Laboratory investigation.
ˍ
RELATED
ARTICLE
Baig
S, Winkler F.
A
holistic view of the malignant organism we call
glioblastoma.
Cell.
2024 Jan 18;187(2):271-273. doi:
10.1016/j.cell.2023.12.021. PMID:
38242083. Comment˰ ˍ
Okamoto T, Mizuta R, Takahashi Y, Otani Y, Sasaki E, Horio Y,
Kuroda H, Matsushita H, Date I, Hashimoto N, Masago K.
Genomic
landscape of glioblastoma without IDH somatic mutation in 42
cases: a comprehensive analysis using RNA sequencing data.
J
Neurooncol. 2024 Apr 23. doi:
10.1007/s11060-024-04628-z. PMID:
38653957. Laboratory investigation˰
ˍ
Dakal TC, Kakde GS, Maurya PK.
Genomic,
epigenomic and transcriptomic landscape of glioblastoma.
Metab
Brain Dis. 2024 Aug 24. doi:
10.1007/s11011-024-01414-8. PMID:
39180605. Review˰ ˍ
Zeller SL, Spirollari E, Chandy AM, Hanft SJ, Gandhi CD,
Jhanwar-Uniyal M.
Understanding the
Genomic Landscape of Glioblastoma: Opportunities for Targeted
Therapies.
Anticancer
Res. 2024 Oct 29;44(11):4677-4690. doi:
10.21873/anticanres.17295. PMID:
39477295. Review. ˍ
Ersöz CC, Berber H, Heper A.
"Grade
4 Astrocytoma vs Grade 4 Glioblastoma: Is
there any clue in H&E?".
Int
J Neurosci. 2024 Dec 16:1-6. doi:
10.1080/00207454.2024.2441994. PMID:
39686561. Observational study. ˍ